rightImage

RDF 2025

Future Pharma R&D China 2025

March 27-28th, 2025 | Guangzhou, China

Advancing in Change,Innovating for the Future

days

hour

mins

secs

1500+

Attendees

150+

Speakers

60+

Sponsors&Exhibitors

100+

Media Partners

1+12

1 Main forum+12 Sub forum

Gala
Dinner

{{SponsorsText.Name}}

visit the website:{{SponsorsText.Href}}

WHAT IS RDF 2025?

The life sciences industry is undergoing unprecedented transformation, driven by rapid technological advances. From AI-assisted drug discovery and gene editing to mRNA vaccines, these innovations are reshaping global pharmaceutical R&D and bringing new hope to patients. Emerging fields like cell and gene therapies are advancing at breakneck speed, offering vast potential for medical breakthroughs.

However, the increasingly complex global regulatory landscape presents significant challenges in bringing these innovations to market. From clinical trial design and data governance to market access and patient availability, each step of the development process is now more critical and uncertain.


Future Pharma R&D China 2025 is the premier annual event for global pharmaceutical leaders and innovators, providing a platform to explore key areas such as drug development, clinical trials, regulatory hurdles, and global market entry. The conference will focus on breakthrough innovations, next-generation therapies, and the future landscape of pharmaceutical R&D, fostering industry collaboration and breaking down boundaries to uncover new opportunities.


Future Pharma R&D China 2025 will gather global leaders from top pharmaceutical companies, biotech firms, regulatory bodies, and key stakeholders in the healthcare ecosystem. Through keynote sessions, focused discussions, and networking opportunities, the event will provide an in-depth analysis of industry trends, promote technical cooperation, and support the growth of the life sciences industry.


Looking forward to meeting you in Guangzhou!


Best Regards!

Organizing Committee of Future Pharma R&D China 2025

AGENDA AT A GLANCE


Focus on Key Issues


Global Trends in Pharmaceutical Innovation

Technology and Capital Driving Pharmaceutical Innovation

Global Market Access and Compliance Strategies

Small Molecule Drug

New Targets, New Breakthroughs


Tackling Undruggable Targets


Clinical Development Strategies for Small Molecule Drugs


Innovations and Future Trends in Small Molecule Drug Applications

Antibody Drug and ADC

Cutting-Edge Advances in Bispecific and Multispecific Antibodies


Differentiated Development of ADC Drugs

Cell and Gene Therapy

Breakthroughs in Cell Therapy


Gene Editing and Therapy Innovations


Emerging Therapies in CGT


CGT Drug CMC Process Development

Peptide Drug

Innovations in Peptide Synthesis and Design


Peptide Drugs for Oncology and Immunotherapy

Radiopharmaceutical
Development and
Applications

Advancements in Radiopharmaceutical Technology


Regulatory and Clinical Challenges in Radiopharmaceuticals

Nucleic Acid
and mRNA Drug

Breakthroughs in Nucleic Acid Therapies


Delivery Technologies and Innovations for Nucleic Acid Drugs


mRNA Vaccine and Drug Development Progress and Future ApplicationsmRNA

AI and Big Data:
Unlocking the Future
of Drug Discovery

AI-Driven Target Identification


Data Science in Drug Design and Optimization


Integration of AI in Drug Development WorkflowAI


Smart Clinical Trials and Data Analytics

Early Drug Development
and Translational
Medicine Forum

Target Discovery and Lead Compound Screening


Innovative Drug Discovery From Design to Validation


Early Drug Development Translational Challenges and Opportunities

Clinical Trial Operations
and Innovation

Digital and Decentralized Clinical Trials


Managing Global Multi-Center Clinical Trials


Data Management and Compliance in Clinical Trials


Patient-Centric Innovations in Clinical Trials

Immuno-Oncology
Drug Development

Advances in Cancer Immunotherapy


Personalized Cancer Immunotherapy and Novel Targets

Pharma BD and
Business Collaboration

Pharma Collaboration and BD Transaction Strategies


※ Roadshow

Global Market Access
and Cross-border Pharma
Collaboration

Launching Innovative Drugs Globally


Cross-border Collaborations for Pharma R&D


Navigating Regulatory Challenges for Global Market Access

WHO SHOULD ATTEND

INTERESTED IN SPONSORING

Give your brand exposure and formal recognition which will convert to more networking and business opportunities

Presentation

Sponsor

+5 DELEGATES

REGISTER NOW

Exhibition

Sponsor

+4 DELEGATES

REGISTER NOW

Luncheon

Sponsor

+5 DELEGATES

REGISTER NOW

Cocktail Party

Sponsor

+5 DELEGATES

REGISTER NOW

Insertion

Sponsor

+1 DELEGATES

REGISTER NOW

Delegate Bags

Sponsor

+3 DELEGATES

REGISTER NOW